The company’s profit grew 27% year-over-year to RON28.2 million in the analysed period.
Biofarm carried out investments of over RON10 million in January-June 2019.
Biofarm is controlled by regional investment fund SIF Muntenia (SIF4.RO) with 50.9%, SIF Banat-Crisana (SIF1.RO) with 36.7%, and the remaining shares are distributed among various investors on the Bucharest stock market.
Biofarm ranks fifth among the largest pharmaceutical producers in Romania, by the sales registered in 2018.
Some 120 firms operate on the local pharmaceuticals market, generating total sales of over RON2.5 billion, according to Trade Register data.